8FE0
Human GAR transformylase in complex with GAR substrate and AGF305 inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 4.2.2 |
Synchrotron site | ALS |
Beamline | 4.2.2 |
Temperature [K] | 100 |
Detector technology | CMOS |
Collection date | 2020-06-25 |
Detector | RDI CMOS_8M |
Wavelength(s) | 1.000 |
Spacegroup name | P 32 2 1 |
Unit cell lengths | 74.879, 74.879, 100.616 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 39.755 - 2.220 |
R-factor | 0.2076 |
Rwork | 0.205 |
R-free | 0.25160 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5j9f |
RMSD bond length | 0.007 |
RMSD bond angle | 1.058 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | PHENIX (1.13-2998) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 39.755 | 2.290 |
High resolution limit [Å] | 2.220 | 2.220 |
Rmeas | 0.505 | |
Rpim | 0.161 | 0.929 |
Number of reflections | 16652 | 1501 |
<I/σ(I)> | 7.1 | |
Completeness [%] | 100.0 | |
Redundancy | 9.7 | |
CC(1/2) | 0.969 | 0.362 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 7.5 | 277 | 0.1 M Tris-HCl pH 7.5, 0.33 M NaCl, 16-21% PEG 4000, and 2% PEG 400 |